How scalable are IVF firms for PE/VC investments amid regulatory uncertainty?

By Joseph Rai

  • 29 Nov 2016
Premium
Credit: Thinkstock

Just a couple of months after the Cabinet approved a bill to ban commercial surrogacy, two contrasting developments occurred in the in vitro fertilisation (IVF) market involving private equity players in the country. Firstly, a private equity firm made a fairly good investment in a home-grown IVF and secondly, a ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.